Literature DB >> 2527583

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis.

J F Marshall1, R Navarrete, J N Joyce.   

Abstract

Autoradiographic experiments performed on rats with unilateral mesotelencephalic 6-hydroxydopamine (6-OHDA) injections revealed reduced binding of [3H]SCH23390 to D1 receptors in the striatum ipsilateral to the neurotoxin as well as increased binding of [3H]spiroperidol to D2 receptors in that hemisphere. These opposite influences of injury on the dopamine receptor subtypes occurred in rats sacrificed at 2 weeks or 11 months postoperatively, but neither change was evident at 4 days postoperatively. Equilibrium saturation analysis performed on rats sacrificed at 8 weeks postoperatively indicated that D1 and D2 receptor changes reflected altered Bmax values without KD modifications. Topographic analysis of the D1 decline by quantitative autoradiography revealed that the D1 decrease was greater in dorsal striatum than ventrally. Those striatal regions that showed greater declines in D1 density correspondingly had the greater losses of [3H]mazindol binding after the denervation, suggesting that the decline of D1 binding is a postsynaptic consequence of the reduced mesostriatal dopaminergic innervation. The findings indicate opposite influences of injury on D2 and D1 receptor levels and raise important questions concerning the mechanism by which 6-OHDA injection affects the D1 sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527583     DOI: 10.1016/0006-8993(89)91160-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Neural responses in multiple basal ganglia regions following unilateral dopamine depletion in behaving rats performing a treadmill locomotion task.

Authors:  Jing-Yu Chang; Li-Hong Shi; Fei Luo; Donald J Woodward
Journal:  Exp Brain Res       Date:  2005-12-21       Impact factor: 1.972

Review 2.  Pathophysiology of parkinsonism.

Authors:  Adriana Galvan; Thomas Wichmann
Journal:  Clin Neurophysiol       Date:  2008-05-07       Impact factor: 3.708

3.  Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy.

Authors:  Anne M Landau; Aage Ko Alstrup; Helene Audrain; Steen Jakobsen; Mette Simonsen; Arne Møller; Poul Videbech; Gregers Wegener; Albert Gjedde; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-16       Impact factor: 6.200

4.  Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

Authors:  E Bezard; S Dovero; C Prunier; P Ravenscroft; S Chalon; D Guilloteau; A R Crossman; B Bioulac; J M Brotchie; C E Gross
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

5.  Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates.

Authors:  Anne M Landau; M Mallar Chakravarty; Campbell M Clark; Athanasios P Zis; Doris J Doudet
Journal:  Neuropsychopharmacology       Date:  2010-10-13       Impact factor: 7.853

6.  D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

Authors:  Charles R Gerfen; Shigehiro Miyachi; Ronald Paletzki; Pierre Brown
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

7.  6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.

Authors:  D G Cole; L A Kobierski; C Konradi; S E Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes).

Authors:  Laura M Harrison; Gerald J Lahoste; David N Ruskin
Journal:  Brain Res       Date:  2008-10-02       Impact factor: 3.252

Review 9.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.